# Anthony E. Lang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anthony-e-lang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 143,807 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 167 |
| i10-index | 904 |
| Last Known Institution | University Health Network |
| OpenAlex ID | https://openalex.org/A5000826850 |
| ORCID iD | https://orcid.org/0000-0003-1229-3667 |
| Works | 1,487 |

## Researcher papers

Showing 12 of 20.

- [Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results](https://scholariq.org/papers/movement-disorder-society-sponsored-revision-of-the-unified-parkinson-s-disease/)
- [MDS clinical diagnostic criteria for Parkinson's disease](https://scholariq.org/papers/mds-clinical-diagnostic-criteria-for-parkinson-s-disease/)
- [Parkinson disease](https://scholariq.org/papers/parkinson-disease/)
- [Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria](https://scholariq.org/papers/clinical-diagnosis-of-progressive-supranuclear-palsy-the-movement-disorder/)
- [Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease](https://scholariq.org/papers/multicenter-analysis-of-glucocerebrosidase-mutations-in-parkinson-s-disease/)
- [Criteria for the diagnosis of corticobasal degeneration](https://scholariq.org/papers/criteria-for-the-diagnosis-of-corticobasal-degeneration/)
- [Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study](https://scholariq.org/papers/phenotype-genotype-and-worldwide-genetic-penetrance-of-lrrk2-associated/)
- [Consensus statement on the diagnosis of multiple system atrophy](https://scholariq.org/papers/consensus-statement-on-the-diagnosis-of-multiple-system-atrophy/)
- [MDS research criteria for prodromal Parkinson's disease](https://scholariq.org/papers/mds-research-criteria-for-prodromal-parkinson-s-disease/)
- [Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease](https://scholariq.org/papers/randomized-controlled-trial-of-intraputamenal-glial-cell-line-derived/)
- [Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy](https://scholariq.org/papers/past-present-and-future-of-parkinson-s-disease-a-special-essay-on-the-200th/)
- [Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD](https://scholariq.org/papers/randomized-double-blind-trial-of-glial-cell-line-derived-neurotrophic-factor/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)

## Researcher university

- [University Health Network](https://scholariq.org/institutions/university-health-network/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.